AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11107366 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC dressing changes every 5 or 10 days (Group A)
Number of subjects: 339
Study 11107366 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC dressing changes every 2 days (Group B)
Number of subjects: 339
Study 11107366 — intervention group
Group type: COMPARATOR
Intervention: CVC dressing changes every 5 days (Group B)
Number of subjects: 339
Study 11107366 — intervention group
Group type: COMPARATOR
Intervention: CVC dressing changes every 10 days (Group A)
Number of subjects: 339
Study 9349932 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg twice daily)
Number of subjects: 20
Study 9349932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8399092 — intervention group
Group type: EXPERIMENTAL
Intervention: Gorging pattern (2 meals/d)
Number of subjects: 10
Study 8399092 — intervention group
Group type: COMPARATOR
Intervention: Nibbling pattern (7 meals/d)
Number of subjects: 10
Study 3486112 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms T4 + 150 micrograms KI daily
Number of subjects: 108
Study 3486112 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms T4 + 25 micrograms T3
Number of subjects: 108
Study 3486112 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms T4
Number of subjects: 108
Study 3486112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 3486112 — intervention group
Group type: EXPERIMENTAL
Intervention: KI singly or in combination
Number of subjects: 108
Study 3486112 — intervention group
Group type: COMPARATOR
Intervention: No KI
Number of subjects: 108
Study 28697926 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Literacy (HL) - assessed with the Short Assessment of Health Literacy for Spanish-speaking Adults questionnaire
Number of subjects: 556
Study 26695864 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg
Number of subjects: 46
Study 26695864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 24765827 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic+steroid irrigation of the middle ear
Number of subjects: 100
Study 24765827 — intervention group
Group type: COMPARATOR
Intervention: Self-administration of the same drops with systemic antibiotics
Number of subjects: 100
Study 22809999 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Group (AG)
Number of subjects: 42
Study 22809999 — intervention group
Group type: EXPERIMENTAL
Intervention: Floor Group (FG)
Number of subjects: 42
Study 22809999 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 42
Study 20430241 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (T-CBT) for 12 weeks
Number of subjects: 53
Study 20430241 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 53
Study 18227541 — intervention group
Group type: EXPERIMENTAL
Intervention: Postchemoradiation MR imaging
Number of subjects: 64
Study 18227541 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphologic MR imaging criteria
Number of subjects: 64
Study 18227541 — intervention group
Group type: COMPARATOR
Intervention: Subjective criteria
Number of subjects: 64
Study 15813663 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500mg twice weekly for 6 months
Number of subjects: 11
Study 15813663 — intervention group
Group type: COMPARATOR
Intervention: Usual medications
Number of subjects: 11
Study 12878614 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 MAC sevoflurane
Number of subjects: 6
Study 12878614 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 MAC sevoflurane
Number of subjects: 6
Study 12878614 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 MAC sevoflurane
Number of subjects: 6
Study 12878614 — intervention group
Group type: COMPARATOR
Intervention: 0 MAC sevoflurane (control)
Number of subjects: 6
Study 9872190 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient hydration protocol (1,000 mL clear liquid over 10 h followed by 6 h of IV hydration at 300 mL/h)
Number of subjects: 36
Study 9872190 — intervention group
Group type: COMPARATOR
Intervention: Overnight IV hydration (0.45 normal saline solution at 75 mL/h for 12 h precatheterization and postcatheterization)
Number of subjects: 36
Study 7635723 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-assisted relaxation therapy
Number of subjects: 25
Study 7635723 — intervention group
Group type: COMPARATOR
Intervention: Self-relaxation
Number of subjects: 25
Study 2198156 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirazolac
Number of subjects: 160
Study 2198156 — intervention group
Group type: COMPARATOR
Intervention: Sulindac
Number of subjects: 160
Study 320957 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (mean serum lithium level, 0.9 mEq/liter)
Number of subjects: 24
Study 320957 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 24
Study 320957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 29559428 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based blood glucose management system (GDm-health)
Number of subjects: 203
Study 29559428 — intervention group
Group type: COMPARATOR
Intervention: Standard clinic care
Number of subjects: 203
Study 26098920 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive exercise and conventional physiotherapy
Number of subjects: 61
Study 26098920 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 61
Study 24822382 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-layer compression stockings
Number of subjects: 454
Study 24822382 — intervention group
Group type: COMPARATOR
Intervention: Four-layer bandages
Number of subjects: 454
Study 22550848 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing meditation intervention (n = 30), practiced every morning for 4 weeks.
Number of subjects: 58
Study 22550848 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-meditation, n = 28), normal activities.
Number of subjects: 58
Study 22550848 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing meditation intervention (n = 30).
Number of subjects: 58
Study 22550848 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-meditation, n = 28).
Number of subjects: 58
Study 20610595 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 28
Study 17327863 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 53
Study 17327863 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligofructose-enriched inulin (OF-IN)
Number of subjects: 53
Study 17327863 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei Shirota
Number of subjects: 53
Study 17327863 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve
Number of subjects: 53
Study 17327863 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic combinations
Number of subjects: 53
Study 17327863 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii
Number of subjects: 53
Study 16117981 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of infrared photocoagulation (IRP) and oral micronized purified flavonoid fraction (MPFF)
Number of subjects: 351
Study 16117981 — intervention group
Group type: COMPARATOR
Intervention: Oral micronized purified flavonoid fraction (MPFF) alone
Number of subjects: 351
Study 16117981 — intervention group
Group type: COMPARATOR
Intervention: Infrared photocoagulation (IRP) alone
Number of subjects: 351
Study 16117981 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of MPFF and IRP
Number of subjects: 351
Study 16117981 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up for 90 days
Number of subjects: 351
Study 12023410 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 or 10 mg per day)
Number of subjects: 14
Study 12023410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 10078887 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient CGA consultation coupled with an adherence intervention
Number of subjects: 363
Study 8625179 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral combination antiemetic regimen of metoclopramide (3 mg/kg x 2 then 2 mg/kg x 2 or 4 doses), dexamethasone (20 mg), and diphenhydramine (50 mg x 2 or 3 doses)
Number of subjects: 52
Study 2185156 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course ceftriaxone (100 mg/kg on days one and two and 60 mg/kg thereafter for four, six, or seven days)
Number of subjects: 119
Study 2185156 — intervention group
Group type: COMPARATOR
Intervention: Full course ceftriaxone (eight, 12, or 14 days)
Number of subjects: 119
Study 2185156 — intervention group
Group type: COMPARATOR
Intervention: Secondary exclusion group (20 culture-positive of the 27 children excluded)
Number of subjects: 119
Study 2185156 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (both groups)
Number of subjects: 119
Study 2185156 — intervention group
Group type: COMPARATOR
Intervention: Full course therapy
Number of subjects: 119
Study 94873 — intervention group
Group type: EXPERIMENTAL
Intervention: Micristin (401 patients)
Number of subjects: 802
Study 94873 — intervention group
Group type: COMPARATOR
Intervention: Placebo (401 patients)
Number of subjects: 802
Study 6660438 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur (sustained-release preparation of theophylline), given twice daily
Number of subjects: 19
Study 6660438 — intervention group
Group type: COMPARATOR
Intervention: Nuelin (conventional fast-release preparation), given three times daily
Number of subjects: 19
Study 6660438 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur (sustained-release preparation of theophylline)
Number of subjects: 19
Study 6660438 — intervention group
Group type: COMPARATOR
Intervention: Nuelin (conventional fast-release preparation)
Number of subjects: 19
Study 6660438 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur and Nuelin
Number of subjects: 19
Study 31474174 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 571
Study 31474174 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 571
Study 28508936 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYAN1 10 mg
Number of subjects: 100
Study 28508936 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYAN1 300 mg
Number of subjects: 100
Study 28508936 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYAN1 single ascending doses (10, 25, 50, 100, 150, 200, 300 mg)
Number of subjects: 100
Study 28508936 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYAN1 multiple doses (100, 150, 200, 300 mg every other day)
Number of subjects: 100
Study 28508936 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYAN1
Number of subjects: 100
Study 27797094 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated syringe technique
Number of subjects: 47
Study 27797094 — intervention group
Group type: COMPARATOR
Intervention: Conventional loss of resistance technique
Number of subjects: 47
Study 25110372 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 text messages with recommendations on the management of viral infections and otitis media
Number of subjects: 977
Study 25110372 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (one-day workshop)
Number of subjects: 977
Study 25110372 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 text messages
Number of subjects: 977
Study 22754902 — intervention group
Group type: EXPERIMENTAL
Intervention: Syringeable paste allograft with resorbable extracellular matrix membrane
Number of subjects: 0
Study 22754902 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 19896342 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan (TRP) depletion
Number of subjects: 24
Study 19896342 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 24
Study 17572791 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills training for 12 weeks
Number of subjects: 101
Study 16430123 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-standardised acupuncture (12 sessions)
Number of subjects: 270
Study 16430123 — intervention group
Group type: COMPARATOR
Intervention: Standardised minimal acupuncture (superficial needling of at least 5 of 10 predefined points)
Number of subjects: 270
Study 16430123 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 270
Study 12145771 — intervention group
Group type: COMPARATOR
Intervention: Sedentary (SED)
Number of subjects: 28
Study 12145771 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Resistive Training (LBRT) 3 times/week
Number of subjects: 28
Study 12145771 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Resistive Training (WBRT) 3 times/week
Number of subjects: 28
Study 12145771 — intervention group
Group type: COMPARATOR
Intervention: SED, LBRT, WBRT
Number of subjects: 28
Study 12145771 — intervention group
Group type: EXPERIMENTAL
Intervention: Men vs Women
Number of subjects: 28
Study 9860476 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal pancreaticojejunostomy combined with local pancreatic head excision (LPJ-LPHE)
Number of subjects: 61
Study 9860476 — intervention group
Group type: COMPARATOR
Intervention: Pylorus-preserving pancreatoduodenectomy (PPPD)
Number of subjects: 61
Study 7710029 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural bupivacaine (either infusion of 0.125% or top‐ups of 10 ml of 0.25%)
Number of subjects: 51
Study 7710029 — intervention group
Group type: COMPARATOR
Intervention: Pethidine with intermittent Entonox
Number of subjects: 51
Study 7710029 — intervention group
Group type: COMPARATOR
Intervention: Extradural bupivacaine with 2 micrograms.ml‐1 fentanyl
Number of subjects: 51
Study 7710029 — intervention group
Group type: COMPARATOR
Intervention: No analgesia
Number of subjects: 51
Study 2565997 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphasalazine
Number of subjects: 60
Study 2565997 — intervention group
Group type: COMPARATOR
Intervention: hydroxychloroquine
Number of subjects: 60
Study 341965 — intervention group
Group type: EXPERIMENTAL
Intervention: Photocoagulation treatment
Number of subjects: 48
Study 341965 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 48
Study 30674917 — intervention group
Group type: EXPERIMENTAL
Intervention: MFGM isolate-supplemented experimental formula (EF)
Number of subjects: 0
Study 30674917 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 0
Study 30674917 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-fed infants (BF)
Number of subjects: 0
Study 28816169 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT with iridium implant (40 Gy/20 fractions + 35 Gy/48 hours)
Number of subjects: 104
Study 28816169 — intervention group
Group type: COMPARATOR
Intervention: EBRT alone (66 Gy/33 fractions)
Number of subjects: 104
Study 28816169 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT with iridium implant
Number of subjects: 104
Study 28816169 — intervention group
Group type: COMPARATOR
Intervention: EBRT alone
Number of subjects: 104
Study 24962143 — intervention group
Group type: EXPERIMENTAL
Intervention: Back massage for 20 minutes
Number of subjects: 101
Study 24962143 — intervention group
Group type: COMPARATOR
Intervention: Sitting position for 20 minutes (Control)
Number of subjects: 101
Study 24016561 — intervention group
Group type: EXPERIMENTAL
Intervention: Batroxobin
Number of subjects: 276
Study 24016561 — intervention group
Group type: EXPERIMENTAL
Intervention: Batroxobin + Ginkgo Biloba Leaves Extract (EGb)
Number of subjects: 276
Study 24016561 — intervention group
Group type: EXPERIMENTAL
Intervention: Batroxobin + EGb + Glucocorticoids
Number of subjects: 276
Study 24016561 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb + Glucocorticoids
Number of subjects: 276
Study 24016561 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 276
Study 21228406 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 21
Study 21228406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 19254484 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intensive self-monitoring (blood glucose self-testing with patient training focused on clinician interpretation of results)
Number of subjects: 453
Study 19254484 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive self-monitoring (SMBG with additional training of patients in interpretation and application of results)
Number of subjects: 453
Study 19254484 — intervention group
Group type: COMPARATOR
Intervention: Standardised usual care (control group)
Number of subjects: 453
Study 17768282 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative consultative service promoting the use of titration trials and periodic monitoring during medication maintenance.
Number of subjects: 377
Study 17768282 — intervention group
Group type: COMPARATOR
Intervention: Control group (no collaborative consultative services).
Number of subjects: 377
Study 15060236 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutramigen (unpleasant-tasting protein hydrolysate formula)
Number of subjects: 0
Study 15060236 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfamil (milk-based formula)
Number of subjects: 0
Study 15060236 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutramigen for 3 months and Enfamil for 4 months
Number of subjects: 0
Study 15060236 — intervention group
Group type: EXPERIMENTAL
Intervention: Alimentum (novel hydrolysate formula)
Number of subjects: 0
Study 10989729 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 98
Study 10989729 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 98
Study 8632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplement (210 mumol) + Albendazole (400 mg)
Number of subjects: 309
Study 8632218 — intervention group
Group type: COMPARATOR
Intervention: Albendazole (400 mg) only
Number of subjects: 309
Study 8632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplement (210 mumol) only
Number of subjects: 309
Study 8632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplement + Albendazole (two groups)
Number of subjects: 309
Study 8632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplement + Albendazole (third group)
Number of subjects: 309
Study 1557640 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (folinic acid 200 mg/m2 + 5-FU 370 mg/m2 IV days 1 to 5 followed by weekly 5-FU 600 mg/m2, reduced to 500 mg/m2 due to toxicity)
Number of subjects: 135
Study 1557640 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (5-FU 370 mg/m2 IV days 1 to 5 followed by weekly 5-FU 600 mg/m2)
Number of subjects: 135
Study 1557640 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (initial dosage of 5-FU 600 mg/m2)
Number of subjects: 135
Study 1557640 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (after reduction of 5-FU dosage to 500 mg/m2)
Number of subjects: 135
Study 1557640 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 135
Study 3926508 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin, 150 mg daily for 3 days
Number of subjects: 9
Study 3926508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31107913 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir (TFV) IVR (8-10 mg/day)
Number of subjects: 51
Study 31107913 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir/Levonorgestrel (TFV/LNG) IVR (20 ug/day)
Number of subjects: 51
Study 31107913 — intervention group
Group type: COMPARATOR
Intervention: Placebo IVR
Number of subjects: 51
Study 31107913 — intervention group
Group type: EXPERIMENTAL
Intervention: All IVR users
Number of subjects: 51
Study 28421299 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium polystyrene sulfonate (SPS)
Number of subjects: 20
Study 28421299 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium polystyrene sulfonate (CPS)
Number of subjects: 20
Study 28594772 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood glucose testing four times a day
Number of subjects: 286
Study 28594772 — intervention group
Group type: COMPARATOR
Intervention: Blood glucose testing every other day
Number of subjects: 286
Study 25439432 — intervention group
Group type: EXPERIMENTAL
Intervention: Overnight orthokeratology (OK) contact lens wear
Number of subjects: 26
Study 25439432 — intervention group
Group type: COMPARATOR
Intervention: Conventional rigid gas‐permeable (GP) lenses
Number of subjects: 26
Study 24186588 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held gamma probe (Navigator GPS) used intraoperatively in Group I (Nav)
Number of subjects: 75
Study 24186588 — intervention group
Group type: COMPARATOR
Intervention: No gamma probe used in Group II
Number of subjects: 75
Study 24186588 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study 21929562 — intervention group
Group type: EXPERIMENTAL
Intervention: PLC 1 g/day
Number of subjects: 121
Study 21929562 — intervention group
Group type: EXPERIMENTAL
Intervention: PLC 2 g/day
Number of subjects: 121
Study 21929562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 18241707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracapsular tonsillectomy
Number of subjects: 69
Study 18241707 — intervention group
Group type: COMPARATOR
Intervention: Subcapsular tonsillectomy
Number of subjects: 69
Study 16685543 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Rhino nasal tampons
Number of subjects: 42
Study 16685543 — intervention group
Group type: COMPARATOR
Intervention: Merocel nasal tampons
Number of subjects: 42
Study 14580025 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser ablation
Number of subjects: 40
Study 14580025 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-etched
Number of subjects: 40
Study 14580025 — intervention group
Group type: COMPARATOR
Intervention: Acid-etched then laser-ablated
Number of subjects: 40
Study 14580025 — intervention group
Group type: COMPARATOR
Intervention: Laser-ablated then acid-etched
Number of subjects: 40
Study 10914843 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (4.37 mg daily)
Number of subjects: 824